Financials
- Market Capitalization 5.84 M
- Employee 268
- Founded 2016
- CEO N/A
- Website www.vivos.com
- Headquarter Delaware, United States
- FIGI BBG00H1NZV76
- Industry Medical Devices
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4915 | SINT SiNtx Technologies, Inc. - Common Stock | 1.56 USD | -9.30% | -16.58% | -29.41% | -49.68% | 6.74 M USD | ||
| 4940 | AIDX 20/20 Biolabs, Inc. - Common Stock | 0.57 USD | -3.39% | -5.00% | -26.92% | -98.86% | 6.05 M USD | ||
| 4964 | INBS Intelligent Bio Solutions Inc. - Common Stock | 2.30 USD | +6.48% | +0.44% | -2.54% | -52.87% | 5.50 M USD | ||
| 4965 | ITOC iTonic Holdings Ltd - Class A Ordinary Shares | 0.32 USD | -3.03% | +3.23% | -3.03% | -64.44% | 5.46 M USD |
Frequently asked questions about Vivos Therapeutics, Inc. - Common Stock
What is the Vivos Therapeutics, Inc. - Common Stock stock price today?
The current price of Vivos Therapeutics, Inc. - Common Stock (VVOS) is 0.42. Over the past 24 hours, the stock has changed by -2.33%. Follow the VVOS chart for real-time price dynamics.
What is the stock ticker of Vivos Therapeutics, Inc. - Common Stock?
Vivos Therapeutics, Inc. - Common Stock trades under the ticker VVOS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Vivos Therapeutics, Inc. - Common Stock stock going up?
VVOS has changed by -12.50% over the last week, -25.00% over the last month, and -93.93% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Vivos Therapeutics, Inc. - Common Stock net income for the last quarter?
Vivos Therapeutics, Inc. - Common Stock reported net income of -7.68 M for the last quarter. The previous quarter showed -6.89 M, which means net income changed by -11.45%.
How many employees does Vivos Therapeutics, Inc. - Common Stock have?
As of the latest available data, Vivos Therapeutics, Inc. - Common Stock has 268 employees. Workforce size can provide additional context about the company's scale and operations.
What is Vivos Therapeutics, Inc. - Common Stock EBITDA?
Vivos Therapeutics, Inc. - Common Stock EBITDA is -6.12 M, and its EBITDA margin is -118.95%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Vivos Therapeutics, Inc. - Common Stock stock?
You can buy Vivos Therapeutics, Inc. - Common Stock (VVOS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Vivos Therapeutics, Inc. - Common Stock stock?
Investing in Vivos Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the VVOS chart and related analysis on metatrader.com as part of your research.